NCT03707938View on ClinicalTrials.gov

Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 18, 2018

Primary Completion Date

January 28, 2026

Study Completion Date

January 28, 2026

Conditions
Advanced Lung CarcinomaALK Gene RearrangementLung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Stage IVB Lung Cancer AJCC v8
Interventions
DRUG

Brigatinib

Given PO

PROCEDURE

Local Consolidation Therapy

Undergo local consolidative therapy

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER